Role of Finerenone in the Treatment of Diabetic Kidney Disease: Patient Selection and Clinical Perspectives
Author:
Publisher
Informa UK Limited
Subject
Chemical Health and Safety,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Safety Research,General Medicine
Reference58 articles.
1. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
2. Type 2 diabetes
3. Diagnosis and Management of Type 2 Diabetic Kidney Disease
4. Diabetic Kidney Disease
5. The Global Burden of Diabetic Kidney Disease: Time Trends and Gender Gaps
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Strategies to address diabetic kidney disease burden in Mexico: a narrative review by the Mexican College of Nephrologists;Frontiers in Medicine;2024-06-19
2. Terpenes in the management of chronic kidney disease;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-04-29
3. Optimization of potassium management in patients with chronic kidney disease and type 2 diabetes on finerenone;Expert Review of Clinical Pharmacology;2023-05-23
4. Finerenone cardiorenal effects and its placement in treatment of chronic kidney disease in patients with type 2 diabetes mellitus: A review;Terapevticheskii arkhiv;2023-04-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3